MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
LogicBio Therapeutics, Inc. (Nasdaq:LOGC)
Organization & Developments: LogicBio Therapeutics
Parents
LogicBio Therapeutics, Inc. (Nasdaq:LOGC)
Children
*Gene-editing company with a focus on rare diseases of the liver
*Genetic medicine company focused on genome editing and gene delivery platforms to address rare and serious diseases from infancy through adulthood
*LogicBio's gene delivery platform, sAAVy™, is an adeno-associated virus (AAV) capsid engineering platform designed to optimize gene delivery for treatments in a broad range of indications and tissues.
*LogicBio's genome editing platform, GeneRide®, is a new approach to precise gene insertion harnessing a cell's natural DNA repair process potentially leading to durable therapeutic protein expression levels
2020: LogicBio Therapeutics (LOGC) (FDA) announces FDA places clinical hold on IND submission for LB-001 for treatment of methylmalonic acidemia_www.streetinsider.com
2020: LogicBio: A Speculative Buy For Their GeneRide Platform Based Gene Therapies_seekingalpha.com
2020: Looking In On LogicBio
Jumps
Finance & Acquisitions: LogicBio Therapeutics
Key People: LogicBio Therapeutics